Blue Biotechnology Market Analysis from 2022 to 2034 Containing Market Size, Share along with its CAGR, Forecast and Trends

Top Countries — Revenue

USD Million/Billion
Loading…

Access the full forecast model.

Country-level data · Company profiles · Editable dataset · Analyst consultation included.

Blue Biotechnology Market Analysis — Presence

Geographical Analysis

Click countries to explore
Loading map…

Regional and Country Analysis

Region / Country 2021 (A)2025 (A)2033 (P) CAGR
Globalxxxxxxxxxxxx8.24%
North Americaxxxxxxxxxxxxxxxx
United Statesxxxxxxxxxxxxxxxx
Canadaxxxxxxxxxxxxxxxx
Mexicoxxxxxxxxxxxxxxxx
Europexxxxxxxxxxxxxxxx
United Kingdomxxxxxxxxxxxxxxxx
Francexxxxxxxxxxxxxxxx
Germanyxxxxxxxxxxxxxxxx
Italyxxxxxxxxxxxxxxxx
Russiaxxxxxxxxxxxxxxxx
Spainxxxxxxxxxxxxxxxx
Swedenxxxxxxxxxxxxxxxx
Denmarkxxxxxxxxxxxxxxxx
Switzerlandxxxxxxxxxxxxxxxx
Luxembourgxxxxxxxxxxxxxxxx
Rest of Europexxxxxxxxxxxxxxxx
Asia Pacificxxxxxxxxxxxxxxxx
Chinaxxxxxxxxxxxxxxxx
Japanxxxxxxxxxxxxxxxx
South Koreaxxxxxxxxxxxxxxxx
Indiaxxxxxxxxxxxxxxxx
Australiaxxxxxxxxxxxxxxxx
Singaporexxxxxxxxxxxxxxxx
Taiwanxxxxxxxxxxxxxxxx
South East Asiaxxxxxxxxxxxxxxxx
Rest of APACxxxxxxxxxxxxxxxx
South Americaxxxxxxxxxxxxxxxx
Brazilxxxxxxxxxxxxxxxx
Argentinaxxxxxxxxxxxxxxxx
Colombiaxxxxxxxxxxxxxxxx
Peruxxxxxxxxxxxxxxxx
Chilexxxxxxxxxxxxxxxx
Rest of South Americaxxxxxxxxxxxxxxxx
Middle Eastxxxxxxxxxxxxxxxx
Saudi Arabiaxxxxxxxxxxxxxxxx
Turkeyxxxxxxxxxxxxxxxx
UAExxxxxxxxxxxxxxxx
Egyptxxxxxxxxxxxxxxxx
Qatarxxxxxxxxxxxxxxxx
Rest of Middle Eastxxxxxxxxxxxxxxxx
Africaxxxxxxxxxxxxxxxx
East Africaxxxxxxxxxxxxxxxx
West Africaxxxxxxxxxxxxxxxx
North Africaxxxxxxxxxxxxxxxx
South Africaxxxxxxxxxxxxxxxx

A = Actual · E = Estimated · P = Projected · 🔒 Locked values require full access. Click headers to sort.

Unlock full regional dataset →

Segmentation Analysis


Market size by (Illustrative, 2025)
Share distribution (2025)

Charts are illustrative — exact values, country-level breakdowns, and full forecast in the paid report. Request a Free Sample PDF.

To learn more about market share and segmentation, request the free sample pages.

Competitor Analysis

Blue Biotechnology Market News

  • In September 2021, FDA approved the tisotumab vedotin-tftv drug derived from marine organisms:

The FDA approved tisotumab vedotin-tftv (brand name Tivdak) derived from marine organisms, tissue factor-directed antibody, and microtubule inhibitor conjugate for adult patients with recurrent or metastatic cervical cancer with disease progression on or after chemotherapy.

Click any bar or cell to request the full company profile
Top Companies (In no particular order)2022 (A)2023 (A)2024 (A)2025 (A)
Marinomed Biotech AG••• ••• ••• •••
Marinova••• ••• ••• •••
Aker BioMarine••• ••• ••• •••
Cyanotech Corporation••• ••• ••• •••
Geomarine••• ••• ••• •••
TerSera Therapeutics LLC••• ••• ••• •••

We Provide Regional Breakdown of this Companies and Company specific to any Country, Region, Product/ service as well. We cover market share analysis for publicly listed companies as well as privately held companies, subject to data availability.

Request company profile for validation →

Report Scope & Analysis

Global Blue Biotechnology market size was valued at $3.07 Billion in 2022 and it is forecasted to reach $5.34 Billion by 2030. Blue Biotechnology Industry's Compound Annual Growth Rate will be 8.24% from 2023 to 2030.

Introduction of Blue Biotechnology

Blue biotechnology is a combination of marine and aquatic animals with technology to provide a new energy source and can be utilized to extract novel active chemicals, create novel pharmaceuticals, or boost the production and safety of seafood. It has the capacity to provide solutions to any issue relating to the need for food, human health, and environmental issues. Through the use of zero-waste recirculation, preventative treatment measures, and modifications in the food supply, blue biotechnology will aid in promoting animal welfare and increasing the sustainability of production. Health care and the biological sciences are two fields where blue biotechnology has many uses. Through the use of microorganism testing, it aids in the detection of illnesses.

Analyst Conclusion

Our study will explain complete manufacturing process along with major raw materials required to manufacture end-product. This report helps to make effective decisions determining product position and will assist you to understand opportunities and threats around the globe.

The Blue Biotechnology Market Analysis is witnessing significant growth in the near future.

In 2023, the Enzymes segment accounted for a notable share of the Blue Biotechnology Market Analysis.

Chidanand Bilagi
Chidanand Bilagi Verified Analyst
Senior Research Associate at Cognitive Market Research · Cognitive Market Research
LinkedIn Profile Book a free Consultation

Frequently Asked Questions

The global market value of Blue biotechnology was USD 3.07 Billion in the year 2022 and it is expected to grow up to USD 5.34 Billion in 2030.
The market for Blue biotechnology market is expected to grow with a CAGR of 8.24%.
Factors like increased research and development spending, growing use of marine products in the food, cosmetics, and agricultural sectors are the main factors driving the worldwide market for Blue biotechnology.
Sea Run Holdings Inc., Abbott Laboratories, NEB, Nofima, Earthrise Nutritionals, Lonza Group Ltd., Sams, Tequesta Bioventures, Nutrex Hawai Inc., PharmaMar S.A., New England Biolabs Inc., Cyanotech Corporation, Qingdao Codo International Ltd., Aker Biomarine, NovaMatrix, GlycoMar Ltd., SEPPIC, Royal DSM N.V., Biotech Marine, Aquapharm, Marinova, Prolume Ltd., CP Kelco US Inc are the key leaders in the Blue biotechnology market.
Europe region holds the largest share of the blue biotechnology market.

★ Reviews

Rate this report

Blue Biotechnology Market Analysis — Table of Contents

Disclaimer:
  • This is just a redacted sample pages of the actual deliverable report and only for representative purposes
  • Charts/Graphs/Numbers/data are only for Representative purposes and do not depict actual statistics.
  • The table of Contents differs according to the user License selection. Current Displayed TOC is for the Corporate User License Report Edition. TOC Customization options: Add or Remove section/s Or chapter/s from the report.
  • Specific Tables, Graphs, Sections, and Chapters can be ordered at a discounted price.
  • If applicable; On Request Volume Data will also be provided (at an Additional Cost).

Product Enzymes, Pharma Products, Bulk Chemicals, Biopolymers, Others
Application Bioengineering, Genomics, Vaccine Development, Drug Discovery, Others
End User Hospitals, Pharmaceutical Companies, Biotechnology Companies, Others
List of Competitors Marinomed Biotech AG, Marinova, Aker BioMarine, Cyanotech Corporation, Geomarine, TerSera Therapeutics LLC

Additional data which we are providing for Blue Biotechnology market

Regional Analysis with Investment Focus

Market Forecasts & Scenarios

  • Best-case, base-case, and worst-case forecasts

  • Regulatory impact (Nagoya Protocol, marine biodiversity laws)

  • Scenario modeling for private investment or R&D allocation

  • 1.1 Top Competitors Analysis

    • (Subject to Data Availability (Private Players))

      1.1.1 Global Blue Biotechnology Market Analysis by Key Players
    • 1.1.2 Top Players Ranking 2024
    • 1.1.3 New Product Launch Analysis
    • 1.1.4 Industry Mergers and Acquisition Analysis
  • 1.2 Company Profile (Data Subject to Availability) Sample Format

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      1.2.1 Marinomed Biotech AG
      • 1.2.1.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 1.2.1.2 Business Overview
      • 1.2.1.3 Financials (Subject to data availability)
      • 1.2.1.4 R&D Investment (Subject to data availability)
      • 1.2.1.5 Product Types Specification
      • 1.2.1.6 Business Strategy
      • 1.2.1.7 Recent Developments
      • 1.2.1.8 Management Change
      • 1.2.1.9 S.W.O.T Analysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      1.2.2 Marinova
      • 1.2.2.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 1.2.2.2 Business Overview
      • 1.2.2.3 Financials (Subject to data availability)
      • 1.2.2.4 R&D Investment (Subject to data availability)
      • 1.2.2.5 Product Types Specification
      • 1.2.2.6 Business Strategy
      • 1.2.2.7 Recent Developments
      • 1.2.2.8 Management Change
      • 1.2.2.9 S.W.O.T Analysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      1.2.3 Aker BioMarine
      • 1.2.3.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 1.2.3.2 Business Overview
      • 1.2.3.3 Financials (Subject to data availability)
      • 1.2.3.4 R&D Investment (Subject to data availability)
      • 1.2.3.5 Product Types Specification
      • 1.2.3.6 Business Strategy
      • 1.2.3.7 Recent Developments
      • 1.2.3.8 Management Change
      • 1.2.3.9 S.W.O.T Analysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      1.2.4 Cyanotech Corporation
      • 1.2.4.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 1.2.4.2 Business Overview
      • 1.2.4.3 Financials (Subject to data availability)
      • 1.2.4.4 R&D Investment (Subject to data availability)
      • 1.2.4.5 Product Types Specification
      • 1.2.4.6 Business Strategy
      • 1.2.4.7 Recent Developments
      • 1.2.4.8 Management Change
      • 1.2.4.9 S.W.O.T Analysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      1.2.5 Geomarine
      • 1.2.5.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 1.2.5.2 Business Overview
      • 1.2.5.3 Financials (Subject to data availability)
      • 1.2.5.4 R&D Investment (Subject to data availability)
      • 1.2.5.5 Product Types Specification
      • 1.2.5.6 Business Strategy
      • 1.2.5.7 Recent Developments
      • 1.2.5.8 Management Change
      • 1.2.5.9 S.W.O.T Analysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      1.2.6 TerSera Therapeutics LLC
      • 1.2.6.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 1.2.6.2 Business Overview
      • 1.2.6.3 Financials (Subject to data availability)
      • 1.2.6.4 R&D Investment (Subject to data availability)
      • 1.2.6.5 Product Types Specification
      • 1.2.6.6 Business Strategy
      • 1.2.6.7 Recent Developments
      • 1.2.6.8 Management Change
      • 1.2.6.9 S.W.O.T Analysis

  • 2.1 Global Blue Biotechnology Market Analysis
  • 2.2 Global Blue Biotechnology Market Analysis by Region
  • 2.3 Global Blue Biotechnology Market Analysis by Product
  • 2.4 Global Blue Biotechnology Market Analysis by Application
  • 2.5 Global Blue Biotechnology Market Analysis by End User
  • 2.6 Global Blue Biotechnology Market Analysis by Key Players

  • 3.1 North America Blue Biotechnology Market Analysis
  • 3.2 North America Blue Biotechnology Market Analysis by Country
  • 3.3 North America Blue Biotechnology Market Analysis by Product
  • 3.4 North America Blue Biotechnology Market Analysis by Application
  • 3.5 North America Blue Biotechnology Market Analysis by End User
  • 3.6 North America Blue Biotechnology Market Analysis by Key Players

  • 4.1 Europe Blue Biotechnology Market Analysis
  • 4.2 Europe Blue Biotechnology Market Analysis by Country
  • 4.3 Europe Blue Biotechnology Market Analysis by Product
  • 4.4 Europe Blue Biotechnology Market Analysis by Application
  • 4.5 Europe Blue Biotechnology Market Analysis by End User
  • 4.6 Europe Blue Biotechnology Market Analysis by Key Players

  • 5.1 Asia Pacific Blue Biotechnology Market Analysis
  • 5.2 Asia Pacific Blue Biotechnology Market Analysis by Country
  • 5.3 Asia Pacific Blue Biotechnology Market Analysis by Product
  • 5.4 Asia Pacific Blue Biotechnology Market Analysis by Application
  • 5.5 Asia Pacific Blue Biotechnology Market Analysis by End User
  • 5.6 Asia Pacific Blue Biotechnology Market Analysis by Key Players

  • 6.1 South America Blue Biotechnology Market Analysis
  • 6.2 South America Blue Biotechnology Market Analysis by Country
  • 6.3 South America Blue Biotechnology Market Analysis by Product
  • 6.4 South America Blue Biotechnology Market Analysis by Application
  • 6.5 South America Blue Biotechnology Market Analysis by End User
  • 6.6 South America Blue Biotechnology Market Analysis by Key Players

  • 7.1 Middle East Blue Biotechnology Market Analysis
  • 7.2 Middle East Blue Biotechnology Market Analysis by Country
  • 7.3 Middle East Blue Biotechnology Market Analysis by Product
  • 7.4 Middle East Blue Biotechnology Market Analysis by Application
  • 7.5 Middle East Blue Biotechnology Market Analysis by End User
  • 7.6 Middle East Blue Biotechnology Market Analysis by Key Players

  • 8.1 Africa Blue Biotechnology Market Analysis
  • 8.2 Africa Blue Biotechnology Market Analysis by Country
  • 8.3 Africa Blue Biotechnology Market Analysis by Product
  • 8.4 Africa Blue Biotechnology Market Analysis by Application
  • 8.5 Africa Blue Biotechnology Market Analysis by End User
  • 8.6 Africa Blue Biotechnology Market Analysis by Key Players

  • 9.1 Enzymes
    • 9.1.1 Global Enzymes Market
    • 9.1.2 Global Enzymes Market by Region
  • 9.2 Pharma Products
    • 9.2.1 Global Pharma Products Market
    • 9.2.2 Global Pharma Products Market by Region
  • 9.3 Bulk Chemicals
    • 9.3.1 Global Bulk Chemicals Market
    • 9.3.2 Global Bulk Chemicals Market by Region
  • 9.4 Biopolymers
    • 9.4.1 Global Biopolymers Market
    • 9.4.2 Global Biopolymers Market by Region
  • 9.5 Others
    • 9.5.1 Global Others Market
    • 9.5.2 Global Others Market by Region

  • 10.1 Bioengineering
    • 10.1.1 Global Bioengineering Market
    • 10.1.2 Global Bioengineering Market by Region
  • 10.2 Genomics
    • 10.2.1 Global Genomics Market
    • 10.2.2 Global Genomics Market by Region
  • 10.3 Vaccine Development
    • 10.3.1 Global Vaccine Development Market
    • 10.3.2 Global Vaccine Development Market by Region
  • 10.4 Drug Discovery
    • 10.4.1 Global Drug Discovery Market
    • 10.4.2 Global Drug Discovery Market by Region
  • 10.5 Others
    • 10.5.1 Global Others Market
    • 10.5.2 Global Others Market by Region

  • 11.1 Hospitals
    • 11.1.1 Global Hospitals Market
    • 11.1.2 Global Hospitals Market by Region
  • 11.2 Pharmaceutical Companies
    • 11.2.1 Global Pharmaceutical Companies Market
    • 11.2.2 Global Pharmaceutical Companies Market by Region
  • 11.3 Biotechnology Companies
    • 11.3.1 Global Biotechnology Companies Market
    • 11.3.2 Global Biotechnology Companies Market by Region
  • 11.4 Others
    • 11.4.1 Global Others Market
    • 11.4.2 Global Others Market by Region

  • 12.1 Market Drivers
  • 12.2 Market Restraints
  • 12.3 Market Trends
  • 12.4 Market Opportunity
  • 12.5 Technological Road Map (Subject to Data Availability)
  • 12.6 Product Life Cycle (Subject to Data Availability)
  • 12.7 Customer and Buyer Behavior Analysis
    • 12.7.1 Consumer Demographics and Target Audience Assessment
    • 12.7.2 Digital Engagement, Customer Experience & Relationship Analysis
    • 12.7.3 Customer Buying Behavior & Purchase Decision Analysis
    • 12.7.4 Vendor Selection, Supplier Preferences & Future Demand Trends
    • 12.7.5 Pricing, Affordability & Value Perception Analysis
    • 12.7.6 Customer Segmentation & Demand Pattern Analysis
  • 12.8 PESTEL Analysis
    • 12.8.1 Political Factors
    • 12.8.2 Economic Factors
    • 12.8.3 Social Factors
    • 12.8.4 Technological Factors
    • 12.8.5 Legal Factors
    • 12.8.6 Environmental Factors
  • 12.9 Industrial Chain Analysis (Subject to Data Availability)
    • 12.9.1 Industry Chain Analysis
    • 12.9.2 Manufacturing Cost Analysis
    • 12.9.3 Supply Side Analysis
      • 12.9.3.1 Raw Material Analysis
      • 12.9.3.2 Raw Material Procurement Analysis
      • 12.9.3.3 Raw Material Price Trend Analysis
  • 12.10 Porter’s Five Forces Analysis
    • 12.10.1 Bargaining Power of Suppliers
    • 12.10.2 Bargaining Power of Buyers
    • 12.10.3 Threat of New Entrants
    • 12.10.4 Threat of Substitutes
    • 12.10.5 Degree of Competition
  • 12.11 Patent Analysis (Subject to Data Availability)
  • 12.12 ESG Analysis
  • 12.13 Geopolitical Outlook
    • 12.13.1 Global Power Realignment & Strategic Alliances
    • 12.13.2 Geopolitical Risk Landscape & Conflict Hotspots
    • 12.13.3 International Trade Relations & Market Access Environment
    • 12.13.4 Regulatory & Policy Shifts Impacting Cross-Border Operations
    • 12.13.5 Supply Chain Resilience, Localization & Resource Nationalism
    • 12.13.6 Technology Sovereignty & Digital Geopolitics
    • 12.13.7 Strategic Implications for Investment, Growth & Market Entry

  • This chapter isn't just about technology; it’s about certainty. We show you how AI is being used in leading industries so you can apply those same 'High-Speed' and 'High-Accuracy' principles to your own market strategy

    12.14 AI & Market Transformation
    • 12.14.1 Competitive Landscape Disruption & Strategic Shifts
    • 12.14.2 AI-Driven Transformation of Industry Value Chain
    • 12.14.3 Evolution of Business Models & Revenue Streams
    • 12.14.4 AI-Driven Product, Service & Innovation Transformation
    • 12.14.5 Customer Behavior, AI Adoption & Future Market Evolution

  • 13.1 Country 1
    • 13.2 Country 2
    • 13.3 Country 3
    • 13.4 Country 4
    • 13.5 Country 5
    • 13.6 Country 6
    • 13.7 Country 7
    • 13.8 Country 8
    • 13.9 Country 9
    • 13.10 Country 10

    • 14.1 Key Takeaways

    • Here the analyst will summarize the content of entire report and will share his view point on the current industry scenario and how the market is expected to perform in the near future. The points shared by the analyst are based on his/her detailed in-depth understanding of the market during the course of this report study. You will be provided exclusive rights to interact with the concerned analyst for unlimited time pre purchase as well as post purchase of the report.

      14.2 Analyst Point of View
    • 14.3 Assumptions and Acronyms

    • 15.1 Primary Data Collection
      • 15.1.1 Steps for Primary Data Collection
        • 15.1.1.1 Identification of KOL
      • 15.1.2 Backward Integration
      • 15.1.3 Forward Integration
      • 15.1.4 How Primary Research Help Us
      • 15.1.5 Modes of Primary Research
    • 15.2 Secondary Research
      • 15.2.1 How Secondary Research Help Us
      • 15.2.2 Sources of Secondary Research
    • 15.3 Data Validation
      • 15.3.1 Data Triangulation
    • 15.4 Data Representation

    Athenaeum AI Dashboard

    Research Framework · 70:30 Primary:Secondary

    Our Proprietary Methodology

    Cognitive Market Research and Consulting "The Full Truth" methodology — a rigorous triangulation process that combines primary research, secondary validation, and expert calibration. Implemented by Chidanand Bilagi and team for the Blue Biotechnology Market Analysis Market analysis.

    01

    Primary Intelligence Gathering

    Direct interviews with 50+ industry stakeholders including manufacturers, distributors, end-users, and regulatory bodies across all six regions.

    02

    Secondary Data Triangulation

    Cross-referencing against trade databases, customs records, financial filings, patent databases, and verified industry publications.

    03

    Expert Validation Protocol

    Each data point undergoes validation by minimum two independent domain experts with 15+ years of industry experience.

    04

    Athenaeum AI Processing

    Our proprietary AI platform aggregates, normalizes, and identifies patterns across 10,000+ data points to surface non-obvious insights.

    05

    Editorial & QA Review

    Final review by senior analysts ensures accuracy, coherence, and actionability of all insights and recommendations.

    Data Assurance Metrics
    Data Points Validated 10,400+
    Expert Interviews 54
    Countries Covered 39+
    Company Profiles 6+
    Forecast Accuracy (Historical) 94.2%
    Report Pages 250+
    Analytical Coverage
    Market Sizing Revenue Forecast CAGR Analysis Competitor Benchmarking SWOT Porter's Analysis PESTEL Value Chain ESG Analysis Tariff Impact Patent Mapping Tech Trends

    To maintain the integrity of our proprietary methodology and protect our elite expert network, specific source disclosures are reserved for full-access partners. Our research framework is anchored by a 70:30 primary-to-secondary ratio, ensuring your strategy is driven by real-time market intelligence rather than recycled, publicly available, or AI-generated data. Every deliverable includes an exhaustive source directory and grants direct analyst access.

    Sources from the Chemical & Materials Industry

    How We Serve You

    The Three Pillars of End-to-End Market Research Services

    We don't just hand over data. We partner with your team across three integrated service lines — each designed to give you decision-grade intelligence on the Blue Biotechnology Market Analysis market.

    Service 01

    Market Survey

    B2B B2C

    Structured primary research across both B2B and B2C channels. We design and execute custom surveys targeting manufacturers, distributors, procurement heads, and end-consumers in the blue biotechnology market analysis ecosystem — validated by our global panel of 10,000+ industrial respondents.

    What's Included
    • Buyer intent & sentiment analysis
    • Purchase cycle mapping
    • Price sensitivity research
    • Channel preference profiling
    • Competitive perception study
    Most Requested
    Service 02

    Customized Market Data & Reports

    Custom Ready Report

    Choose from our ready-to-access 8th Edition report or commission a fully customized dataset tailored to your exact strategic questions. Cross-splits, custom geographies, proprietary segmentation — we build the intelligence asset your board actually needs.

    What's Included
    • Ready syndicate report (250+ pages)
    • Custom data scope & segmentation
    • Excel quantitative models
    • Board-ready PPT with key findings
    • Secure cloud portal access
    Service 03

    Strategic Consultation

    With Survey With Report

    Every survey and every report comes with dedicated analyst consultation. Our senior research team walks your leadership through findings, answers strategic questions in real-time, and helps translate data into your next board presentation or investment thesis.

    What's Included
    • Dedicated analyst assigned to you
    • Live walkthrough of findings
    • Strategic Q&A sessions
    • Go-to-market recommendations
    • NDA-protected engagement

    Customize This Report

    Tell us the specific segments, regions, or companies you need — and we will tailor the deliverable to your requirements.